Related Experiment Video
Updated: Oct 2, 2025
09:22
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
12.3K
Chronic Thromboembolic Pulmonary Hypertension: An Update
Barbara Ruaro1, Elisa Baratella2, Gaetano Caforio1
1Department of Pulmonology, Cattinara Hospital, University of Trieste, 34127 Trieste, Italy.
Diagnostics (Basel, Switzerland)
|February 25, 2022
Summary
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, high-mortality condition following pulmonary embolism (PE). Pulmonary endarterectomy (PEA) is the primary treatment for eligible patients, with ongoing advances in surgical techniques and medications.
Area of Science:
- Cardiology
- Pulmonology
- Vascular Surgery
Background:
- Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but serious complication of acute pulmonary embolism (PE).
- CTEPH significantly increases morbidity and mortality due to pulmonary hypertension (PH) severity and right ventricular dysfunction.
- Early diagnosis and appropriate management are crucial for improving patient outcomes.
Purpose of the Study:
- To provide an overview of risk factors associated with CTEPH development.
- To review the latest advancements in diagnostic tools for CTEPH.
- To summarize current and emerging treatment options for CTEPH.
Main Methods:
- Literature review of recent studies on CTEPH.
- Analysis of risk factors, diagnostic modalities, and therapeutic strategies.
- Synthesis of information on surgical eligibility and medical management.
Main Results:
- Pulmonary endarterectomy (PEA) is the preferred treatment for operable CTEPH patients, offering significant improvements.
- Not all patients are candidates for PEA due to distal disease or comorbidities.
- Advances in surgical techniques and PH-specific medications offer additional therapeutic avenues.
Conclusions:
- Careful selection of surgical candidates by an interprofessional team in expert centers is essential.
- A multidisciplinary approach combining surgical and medical management optimizes outcomes for CTEPH patients.
- Continued research into risk factors and treatment innovations is vital for managing this complex condition.
Keywords:
chronic thromboembolic pulmonary hypertension (CTEPH)chronic thromboembolismidiopathic pulmonary arterial hypertension (IPAH)pulmonary artery pressure (PAP)pulmonary thromboendarterectomypulmonary vasodilator therapyMore Related Videos
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
60
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
60
01:27Pulmonary Embolism III: Nursing Management
63
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
63
01:29Pulmonary Embolism I: Introduction
142
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
142
01:30Pulmonary Hypertension: Classification and Pathogenesis
312
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
312
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
271
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
271
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K